Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life - - BioPharm International

ADVERTISEMENT

Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life



Peter Sprinz
PhD, Research Scientist,
Manufacturing Science & Technology—Statistics
Eli Lilly and Company

Add this Podcast feed to your media player



Using Stability Models to Predict Drug Characteristics at the End of Shelf Life

Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen to hear how Lilly has implemented such models, and what they have gained by doing so.



Related Links
Characterizing the Formulation Design Space
Best Practices for Formulation and Manufacturing of Biotech Drug Products
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients

Click here to go to the main podcast page >>>

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines

Click here